Atlas Trials

CTCs and Novel Target Bio-marker Analysis for Prediction and Monitoring of Metastasis/Recurrence in Post-surgery Colorectal Cancer Patients Using MiSelect R Rare Cell System

Clinical trial NCT03013868 · UNKNOWN

Trial details

NCT number
NCT03013868
Sponsor
MiCareo Taiwan Co., Ltd.
Status
UNKNOWN
Study type
OBSERVATIONAL
Circulating Tumor Cells, CTC
Start date
2016-10-01
Primary completion
2020-12-01
Enrollment
200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.